Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Why Shares of Newsmax Are Rising Todayfool.com
Via The Motley Fool · April 7, 2025
Apple Takes the Biggest Hit of the "Magnificent Seven" in Response to Trump Tariffsfool.com
Tariffs will be the focus, but Apple's issues predate the shocking tariff announcement on April 2.
Via The Motley Fool · April 7, 2025
Why Tesla Stock Sank 11.5% in Marchfool.com
Tesla stock is now down over 40% in 2025. Is it time to buy?
Via The Motley Fool · April 7, 2025
3 Under-the-Radar AI Stocks With Market-Beating Potentialfool.com
Innodata, Ambarella, and Symbotic could attract more attention soon.
Via The Motley Fool · April 7, 2025
The Market's Tariff Tumble: 2 Stocks to Buy During This Nasdaq Correctionfool.com
Via The Motley Fool · April 7, 2025
Opendoor: Does It Have a $2.2 Billion Problem or a $2.2 Billion Opportunity?fool.com
Via The Motley Fool · April 7, 2025
Coinbase Global's Options Frenzy: What You Need to Knowbenzinga.com
Via Benzinga · April 7, 2025
Behind the Scenes of Carvana's Latest Options Trendsbenzinga.com
Via Benzinga · April 7, 2025
Is the Market Bullish or Bearish on CACI International?benzinga.com
Via Benzinga · April 7, 2025
What Does the Market Think About Sun Communities?benzinga.com
Via Benzinga · April 7, 2025
P/E Ratio Insights for General Dynamicsbenzinga.com
Via Benzinga · April 7, 2025
How Is The Market Feeling About Privia Health Gr?benzinga.com
Via Benzinga · April 7, 2025
Trump's Tariffs Topple Tech Stocks. Here's What Amazon Investors Should Knowfool.com
Via The Motley Fool · April 7, 2025
Elliott Wave Technical Forecast: Insurance Australia Group Limited - Monday, April 7talkmarkets.com
The analysis aims to provide valuable insights into market trends and potential opportunities.
Via Talk Markets · April 7, 2025
Peter Schiff Says Trump's Tariffs Are 'Dumber Than A Strategic Bitcoin Reserve'benzinga.com
Bitcoin (CRYPTO: BTC) critic Peter Schiff has resurfaced with a fresh round of criticism, targeting both Ethereum (CRYPTO: ETH) and Donald Trump's economic policies as markets are
Via Benzinga · April 7, 2025
What's Going On With Financial Select Sector SPDR Fund (XLF)?benzinga.com
Shares of the Financial Select Sector SPDR Fund are trading lower by 10.6% over the past week. President Donald Trump's announcement of sweeping reciprocal tariffs against key trading partners last week has ignited investor concerns.
Via Benzinga · April 7, 2025
Calamos' New ETFs Promise Market Exposure Without The Meltdownsbenzinga.com
Calamos added 2 new Structured Protection ETFs in April, providing exposure to S&P 500 and Russell 2000 with downside protection and capped gains.
Via Benzinga · April 7, 2025
Which S&P500 stocks are gapping on Monday?chartmill.com
Let's have a look at what is happening on the US markets on Monday. Below you can find the S&P500 gap up and gap down stocks in today's session.
Via Chartmill · April 7, 2025
Why Cava Stock Was Down 23% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022fool.com
Via The Motley Fool · April 7, 2025
Tesla Has Over $200 Million Worth Of Cybertrucks In Inventory—And That's Raising Questions About Demand (Again)benzinga.com
Via Benzinga · April 7, 2025
Major Equity Indices Deeply Oversold, But Widespread Selling Yet To Show Signs Of Letuptalkmarkets.com
Amid fears of tariffs-induced economic slowdown/contraction and indiscriminate selling of stocks, equity bulls are hoping for signs of stability and a relief rally.
Via Talk Markets · April 7, 2025
Monday's session: gap up and gap down stockschartmill.com
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via Chartmill · April 7, 2025
Crude Oil Down 2%; Chanson International Shares Spike Highermarkets/com
Via Benzinga · April 7, 2025
Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorderbenzinga.com
Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.
Via Benzinga · April 7, 2025
Palantir Stock Rises Defying Market Downturn: Retail Shrugs Off Upside As ‘Dead-Cat Bounce’stocktwits.com
The Department of Defense’s move to cut costs exerted downward pressure on Palantir stock even before President Donald Trump’s tariffs hit the market hard.
Via Stocktwits · April 7, 2025